Schedule 13G ownership disclosure

INSYS THERAPEUTICS INC

Security class unavailable · CUSIP: 45824V209

Event date: 2017-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000891092-17-001159
Form type
SC 13G/A
Filer
Insys Therapeutics, Inc.
CIK
CIK 1516479
Filed
Feb 10, 2017
Reporting period
Jan 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub